HIGHLIGHTS
- who: Dennis D. Arnold from the Department of Immunology, University Hospital Zurich, Zurich, Switzerland, Faculty of Medicine, University of Zurich have published the article: Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders, in the Journal: (JOURNAL) of 31/Dec/2020
- what: The aim of this systematic review was to provide a structured and complete overview of the current available studies assessing safety and efficacy of anakinra, bermekimab, canakinumab, gevokizumab, and rilonacept as well as their influence on quality of life (QoL) when used in immune-mediated diseases . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.